Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FR3KT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,914
Award facts
- Contract value 100% obligated
- $49,913.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,913.74 to AmerisourceBergen Drug Corp for Wegovy 2.4 mg/0.75 ml pen injectors, with delivery scheduled to conclude by September 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 million prime vendor agreement that extends through December 2026 and enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, fulfills this order as part of its extensive portfolio of federal medical procurement services. The company's federal contracting activities demonstrate consistent capability in supplying specialized pharmaceutical products across multiple therapeutic domains to the Defense Health Agency and other government healthcare systems. This delivery order for Wegovy, a diabetes and weight management medication, aligns with AmerisourceBergen's established track record of delivering brand-name medications and specialty pharmaceuticals through competitively awarded contracts with the DLA, reflecting the company's role as a strategic supplier for military medical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FR3KT?
SPE2DB25FR3KT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FR3KT worth?
The government has obligated $49,914 on SPE2DB25FR3KT.
Is contract SPE2DB25FR3KT an order under another contract?
Yes. SPE2DB25FR3KT is a delivery order under SPE2DB22D2218, an indefinite delivery contract.
Was contract SPE2DB25FR3KT competed?
The extent of competition for SPE2DB25FR3KT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award